Sarepta Therapeutics (SRPT) PT Lowered to $41 at Oppenheimer

July 18, 2025 8:34 AM EDT Send to a Friend

Oppenheimer analyst Andreas Argyrides lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Sarepta Therapeutics (SRPT) PT Lowered to $41 at Oppenheimer

Member Login

Free News Feed